Loading...
Market
Hims & Hers maintains increased stock value post-GLP-1 announcement by year-end
5
Resolution / Starting Odds
Yes • 50%
No • 50%
Stock market data
Story
Hims & Hers Health Adds GLP-1 Injections for Weight Loss, Stock Soars 30%
May 20, 2024, 01:26 PM
Hims & Hers Health has announced the addition of compounded GLP-1 injections to its weight loss program. The news has positively impacted the company's stock, with $HIMS experiencing a significant increase in value. The stock saw a 10% rise shortly after the announcement and later spiked by 20%. By the end of the day, $HIMS was up 30%. This move positions Hims & Hers Health to offer both compounded GLP-1 weight loss treatments and mainstream options, potentially expanding its market reach in a big market.
View original story
Similar markets
Increase below 20% • 25%
20% to 40% increase • 25%
40% to 60% increase • 25%
Above 60% increase • 25%
Yes • 50%
No • 50%
Increase by over 50% • 25%
Increase by 20-50% • 25%
Increase by less than 20% • 25%
Decrease • 25%
Highly satisfied • 25%
Satisfied • 25%
Neutral • 25%
Dissatisfied • 25%